Water soluble cationic perylene derivatives as possible telomerase inhibitors: the search for selective G-quadruplex

Emanuela Micheli1, Danilo D'Ambrosio, Marco Franceschin

  • 1Dipartimento di Chimica, Sapienza Università di Roma, Roma, Italy.

Insights

Researchers developed new hydrosoluble perylene di-imides (HPDIs) to inhibit telomerase, a cancer marker. These compounds effectively target telomeric G-quadruplex structures, showing improved cancer inhibition and selectivity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Telomerase activity is a hallmark of cancer, making telomerase inhibitors a key area of cancer research.
  • Stabilizing telomeric G-quadruplex structures is a promising strategy for inhibiting telomerase.
  • Small organic molecules are being investigated for their ability to induce or stabilize G-quadruplexes.

Purpose of the Study:

  • To critically analyze hydrosoluble perylene di-imides (HPDIs) as potential telomerase inhibitors.
  • To investigate the structure-activity relationship of HPDIs by modifying hydrophilic side chains.
  • To enhance the efficiency and selectivity of HPDIs for telomeric G-quadruplex structures.

Main Methods:

  • Synthesis and characterization of various hydrosoluble perylene di-imides (HPDIs).
  • Evaluation of HPDIs' ability to bind to and stabilize telomeric G-quadruplex structures.
  • Assessment of telomerase inhibition activity and selectivity against duplex genomic DNA.

Main Results:

  • HPDIs demonstrated significant efficiency in inhibiting telomerase activity.
  • Modification of hydrophilic side chains allowed fine-tuning of HPDI interaction with DNA grooves.
  • Improved selectivity of HPDIs for telomeric G-quadruplex over duplex DNA was achieved.

Conclusions:

  • Hydrosoluble perylene di-imides represent a promising class of compounds for telomerase inhibition.
  • The design strategy of fixing the perylene core and varying side chains enhances inhibitor efficacy and selectivity.
  • These findings support the development of HPDI-based therapeutics for cancer treatment.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...